Skip to main content
. 2021 Jun 28;11:686776. doi: 10.3389/fonc.2021.686776

Figure 2.

Figure 2

TILs and PD-L1 distribution in the overall population, gBRCA-mutant and wild-type tumors at basal assessment. TILs, tumor-infiltrating lymphocytes; gBRCA-wt, germinal BRCA1/2-wild type triple negative tumors; gBRCA-mut, germinal BRCA1/2-mutant tumors; PD-L1, PD-L1 in tumor-infiltrating inflammatory cells.